Your preferences have been updated successfully.
Top 30 Lists
Advent In The Lead To Buy Inventiv For Close To $4B
Private equity firm Advent International is in advanced talks to acquire inVentiv Group Holdings in a deal that could value the U.S. pharmaceutical research firm at close to $4 billion.
READ FULL INVESTMENT ARTICLE
In this article